John L Auerbach sold $104k of MNRO
director at MONRO, INC.. 2,195 shares at an average of $47.47, traded Oct 31, 2022, filed Nov 1, 2022.
Score components
- +15RoleDirector
- +10Trade size$104k at market
- +5Share of holdings soldSold 21% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001209191-22-054961, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Oct 31, 2022 | SOpen-market sale Common Stock | -2,195 | $47.47 | $104k | 8,041 | Nov 1, 2022 |
Related signals
Other insiders at MONRO, INC. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 46Moderate | MNRObuy MONRO, INC. | Peter D Fitzsimmons President and CEO | $251k 12,750 shares | +13% | |
| 41Moderate | MNRObuy MONRO, INC. | Peter D Fitzsimmons President and CEO | $251k 13,350 shares | +16% | |
| 50Moderate | MNRObuy MONRO, INC. | Carl C Icahn owner | $11M 638,659 shares | +14% | |
| 45Moderate | MNRObuy MONRO, INC. | Carl C Icahn owner | $9.7M 639,473 shares | +17% | |
| 47Moderate | MNRObuy MONRO, INC. | Michael T Broderick CEO & President | $161k 5,000 shares | +6% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.